FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

840364008: Teprotumumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3901657017 Teprotumumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3901658010 Teprotumumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3901657017 Teprotumumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3901658010 Teprotumumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Teprotumumab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Teprotumumab (substance) Is a Insulin-like growth factor 1 antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing teprotumumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Teprotumumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only teprotumumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Teprotumumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing teprotumumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Teprotumumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only teprotumumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Teprotumumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start